Kayne Anderson Rudnick Investment Management LLC Abiomed Inc Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $571 - $710	-2 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$251.88 - $324.2 $503 - $648	2 New	2 $1,000
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $5.16 Million - $7.74 Million	-39,505 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$159.31 - $223.54 $609,042 - $854,593	3,823 Added 10.71%	39,505 $6.74 Million
Q3 2019 Nov 14, 2019	BUY	$175.89 - $279.23 $1.54 Million - $2.45 Million	8,765 Added 32.56%	35,682 $6.35 Million
Q2 2019 Aug 14, 2019	BUY	$250.96 - $284.94 $3.26 Million - $3.7 Million	12,983 Added 93.17%	26,917 $7.01 Million
Q1 2019 May 10, 2019	BUY	$276.39 - $362.25 $1.7 Million - $2.22 Million	6,134 Added 78.64%	13,934 $3.98 Million
Q4 2018 Feb 06, 2019	BUY	$281.08 - $444.25 $2.19 Million - $3.47 Million	7,800 New	7,800 $2.54 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account